Subtle cognitive impairments in patients with long-term cure of Cushing's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 6, 2010, Pages 2699-2714

  Tiemensma, Jitske ^a   Kokshoorn, Nieke E ^a   Biermasz, Nienke R ^a   Keijser, Bart Jan S A ^a   Wassenaar, Moniek J E ^a   Middelkoop, Huub A M ^a   Pereira, Alberto M ^a   Romijn, Johannes A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; CUSHING DISEASE; DISEASE ASSOCIATION; FEMALE; FIGURE FLUENCY TEST; FOLLOW UP; HUMAN; HYPOPHYSIS ADENOMA; LEARNING TEST; LETTER DIGIT SUBSTITUTION TEST; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; REY COMPLEX FIGURE TEST; VERBAL LEARNING TEST OF REY; WORD RECOGNITION; ACTH SECRETING ADENOMA; AGED; ANXIETY; COGNITIVE DEFECT; DEPRESSION; ENDOCRINE FUNCTION TEST; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SHORT TERM MEMORY; SURVIVOR; TREATMENT OUTCOME; WECHSLER INTELLIGENCE SCALE;

ACTH-SECRETING PITUITARY ADENOMA; ADULT; AGED; ANXIETY; COGNITION DISORDERS; DEPRESSION; FEMALE; HUMANS; MALE; MEMORY; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PITUITARY ACTH HYPERSECRETION; PITUITARY FUNCTION TESTS; PSYCHIATRIC STATUS RATING SCALES; SURVIVORS; TREATMENT OUTCOME; WECHSLER SCALES;

EID: 77954520401     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2032     Document Type: Article

References (43)

1. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672
2. Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van Aken MO, Voormolen JH, Romijn JA 2007 Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 92:976-981
3. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA 2005 Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 90:3279-3286
4. Whelan TB, Schteingart DE, Starkman MN, Smith A 1980 Neuropsychological deficits in Cushing's syndrome. J Nerv Ment Dis 168:753-757
5. Martignoni E, Costa A, Sinforiani E, Liuzzi A, Chiodini P, Mauri M, Bono G, Nappi G 1992 The brain as a target for adrenocortical steroids: cognitive implications. Psychoneuroendocrinology 17:343-354
6. Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R, Nappi G 1993 Memory impairment in Cushing's disease. Acta Neurol Scand 87:52-55
7. Forget H, Lacroix A, Somma M, Cohen H 2000 Cognitive decline in patients with Cushing's syndrome. J Int Neuropsychol Soc 6:20-29
8. Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE 2001 Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosom Med 63:985-993
9. Michaud K, Forget H, Cohen H 2009 Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging. Brain Cogn 71:1-8
10. León-Carrión J, Atutxa AM, Mangas MA, Soto-Moreno A, Pumar A, Leon-Justel A, Martín-Rodriguez JF, Venegas E, Domínguez- Morales MR, Leal-Cerro A 2009 A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clin Endocrinol (Oxf) 70:192-200
11. Starkman MN, Gebarski SS, Berent S, Schteingart DE 1992 Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 32:756-765
12. Foy MR, Stanton ME, Levine S, Thompson RF 1987 Behavioral stress impairs long-term potentiation in rodent hippocampus. Behav Neural Biol 48:138-149
13. Bodnoff SR, Humphreys AG, Lehman JC, Diamond DM, Rose GM, Meaney MJ 1995 Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci 15(1 Pt 1):61-69
14. Bourdeau I, Bard C, Forget H, Boulanger Y, Cohen H, Lacroix A 2005 Cognitive function and cerebral assessment in patients who have Cushing's syndrome. Endocrinol Metab Clin North Am 34:357-369, ix
15. Fietta P, Fietta P, Delsante G 2009 Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci 63:613-622
16. Brown ES 2009 Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann NY Acad Sci 1179:41-55
17. Starkman MN, Giordani B, Gebarski SS, Schteingart DE 2003 Improvement in learning associated with increase in hippocampal formation volume. Biol Psychiatry 53:233-238
18. Dorn LD, Cerrone P 2000 Cognitive function in patients with Cushing syndrome: a longitudinal perspective. Clin Nurs Res 9:420-440
19. Forget H, Lacroix A, Cohen H 2002 Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 27:367-383
20. Hook JN, Giordani B, Schteingart DE, Guire K, Giles J, Ryan K, Gebarski SS, Langenecker SA, Starkman MN 2007 Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease. J Int Neuropsychol Soc 13:21-29
21. Lezak MD 1995 Neuropsychological assessment. 3rd ed. New York: Oxford University Press
22. Folstein MF, Folstein SE, McHugh PR 1975 "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
23. Wechsler D, Stone CP 1945 Wechsler Memory Scale. New York: Psychological Corporation
24. Rey A 1958 L'examin Clinique en Psyhcologie. Paris: Presses Universitaires de France
25. Rey A 1941 L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 28:286-340
26. Reitan R 1956 Trail making test: manual for administration, scoring, and interpretation. Bloomington, IN: Indiana University
27. Stroop J 1935 Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
28. van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J 2006 The Letter Digit Substitution Test: normative data for 1,858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex. J Clin Exp Neuropsychol 28:998-1009
29. Regard M, Strauss E, Knapp P 1982 Children's production on verbal and non-verbal fluency tasks. Percept Mot Skills 55:839-844
30. Benton AL, Hamsher Kd 1976 Multilingual Aphasia Examination. Iowa City, IA: University of Iowa
31. Luteijn F, Ploeg FAEvd 1983 Manual Groninger Intelligence Test. Lisse, The Netherlands: Swets, Zeitlinger
32. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM 1997 A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27:363-370 (Pubitemid 27139969)
33. Zigmond AS, Snaith RP 1983 The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370
34. Grattan-Smith PJ, Morris JG, Shores EA, Batchelor J, Sparks RS 1992 Neuropsychological abnormalities in patients with pituitary tumours. Acta Neurol Scand 86:626-631 (Pubitemid 23003666)
35. Peace KA, Orme SM, Thompson AR, Padayatty S, Ellis AW, Belchetz PE 1997 Cognitive dysfunction in patients treated for pituitary tumours. J Clin Exp Neuropsychol 19:1-6 (Pubitemid 27122098)
36. Peace KA, Orme SM, Padayatty SJ, Godfrey HP, Belchetz PE 1998 Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clin Endocrinol (Oxf) 49:391-396
37. McEwen BS 2008 Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583:174-185
38. Yehuda R 2002 Post-traumatic stress disorder. N Engl J Med 346:108-114
39. Wolkowitz OM, Burke H, Epel ES, Reus VI 2009 Glucocorticoids: mood, memory, and mechanisms. Ann NY Acad Sci 1179:19-40
40. Schulz KF, Grimes DA 2005 Multiplicity in randomised trials I: endpoints and treatments. Lancet 365:1591-1595
41. Schulz KF, Grimes DA 2005 Multiplicity in randomised trials II: subgroup and interim analyses. Lancet 365:1657-1661
42. Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F 2004 Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369-5376
43. Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA 2006 Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:3364-3369